Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2012, Vol. 17 ›› Issue (2): 171-174.

Previous Articles     Next Articles

Effect of Wedelolactone on COX-2, NO and TNF-α expression in lipopolysaccharide induced RAW264.7 cells

CHEN Jie1, LI Rui-ming1, XU Jing2, GUAN Bi-qiong2, LUO Zi-ling2   

  1. 1Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China;
    2Department of Pharmacy, the Third Affiliated Hospital , Southern Medical University, Guangzhou 510630, Guangdong, China
  • Received:2011-12-07 Revised:2012-01-17 Online:2012-02-26 Published:2012-03-12

Abstract: AIM: To study effect of Wedelolactone on COX-2, NO and TNF-α expression in lipopolysaccharide (LPS) induced RAW264.7 cells.METHODS: The contents of PGE2, TNF-α, NO were detected by ELISA methods, expression of COX-2 protein in RAW264.7 cells was measured by MTT assay, in the presence or absence of 10 μg/mL lipopolysaccharide (LPS) or Wedelolactone (0.2, 2, 20 μmol/L).RESULTS: The expression of COX-2 protein was significantly induced by LPS, Wedelolactone inhibited the expression of COX-2 protein significantly elicited by LPS in RAW264.7 cells; LPS-induced PGE2, TNF-α, NO was significantly inhibited by Wedelolactone in RAW264.7 cells, in dose dependent manners.CONCLUSION: The anti-inflammatory mechanisms of TGA may suppress production of PGE2 through inhibiting COX-2 gene expression, and inhibit activity of NO and TNF-α.

Key words: Wedelolactone, Lipopolysaccharide, Cell culture

CLC Number: